ArticleJournal of cellular and molecular medicine2024

MicroRNA-26a alleviates tubulointerstitial fibrosis in diabetic kidney disease by targeting PAR4.

Gaoting Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.